Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 760-766

  Ricci, Susanna ^a,d   Medaglini, Donata ^a   Rush, Catherine M ^a,e   Marcello, Alessandro ^b,f   Peppoloni, Samuele ^c   Manganelli, Riccardo ^a,g   Palú, Giorgio ^b   Pozzi, Gianni ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c CHIRON VACCINES   (Italy)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^g PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MONOMER;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GORDONII;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, VIRAL; RECOMBINANT PROTEINS; STREPTOCOCCUS;

EID: 0033984376     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.760-766.2000     Document Type: Article

References (57)

1. Amin, T., and T. R. Hirst. 1994. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Protein Expr. Purif. 5:198-204.
2. Apter, F. M., P. Michetti, L. S. Winner III, J. A. Mack, J. J. Mekalanos, and M. R. Neutra. 1993. Analysis of the role of antilipopolysaccharide and anticholera toxin immunoglobulin A antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect. Immun. 61:5279-5285.
3. Backstrom, M., V. Shahabi, S. Johansson, S. Teneberg, A. Kjellberg, H. Miller-Podraza, J. Holmgren, and M. Lebens. 1997. Structural basis for differential receptor binding of cholera and Escherichia coli heat-labile toxins: influence of heterologous amino acid substitutions in the cholera B-subunit. Mol. Microbiol. 24:489-497.
4. Chamberlain, L., J. M. Wells, K. Robinson, K. Schofield, and R. Le Page. 1997. Mucosal immunization with recombinant Lactococcus lactis. p. 83-106. In G. Pozzi and J. M. Wells (ed.), Gram-positive bacteria. Vaccine vehicles for mucosal immunization. RG Landes, Austin, Tex.
5. Clements, J. D., and S. El-Morshidy. 1984. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect. Immun. 46:564-569.
6. Coffman, R. L., B. W. Seymour, D. A. Lebman, D. D. Hiraki, J. A. Christiansen, B. Shrader, H. M. Cherwinski, H. F. Savelkoul, F. D. Finkelman, M. W. Bond, and T. R. Mosmann. 1988. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102: 5-28.
7. Dale, J. B., and E. C. Chiang. 1995. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J. Infect. Dis. 171:1038-1041.
8. Dallas, W. S., and S. Falkow. 1980. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 288:499-501.
9. de Geus, B., M. Dol-Bosman, J. W. Scholten, W. Stok, and A. Bianchi. 1997. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunisation. Vaccine 15:1110-1113.
10. Dertzbaugh, M. T., D. L. Peterson, and F. L. Macrina. 1997. Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein. Infect. Immun. 58:70-79.
11. Dickinson, B. L., and J. D. Clements. 1996. Use of Escherichia coli heat-labile enterotoxin as an oral adjuvant p. 7.1-87. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.
12. Di Fabio, S., D. Medaglini, C. M. Rush, G. Corrias, G. L. Panzini, M. Pace, P. Verani, G. Pozzi, and F. Titti. 1997. Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV-16 antigens. Vaccine 16:485-492.
13. Elson, C. O. 1996. Cholera toxin as a mucosal adjuvant. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.
14. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2741.
15. Harokopakis, E., G. Hajishengallis, T. E. Greenway, M. W. Russel, and S. M. Michalek. 1997. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect. Immun. 65:1445-1454.
16. Hirabayashi, Y., S. I. Tamura, Y. Suzuki, T. Nagamine, C. Aizawa, and K. Shimada. 1991. H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus hemoagglutinin. Immunology 72:329-335.
17. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature 292:413-417.
18. Holmgren, J., M. Lindblad, P. Fredman, L. Svennerholm, and H. Myrvold. 1985. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 89:27-35.
19. Holmgren, J., and A. M. Svennerholm. 1996. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea p. 241-253. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.
20. Houghten, R. A., R. F. Engert, J. M. Ostresh, S. R. Hoffman, and F. A. Klipstein. 1985. A completely synthetic toxoid vaccine containing Escherichia coli heat-stable and antigenic determinants of the heat-labile toxin B subunit. Infect. Immun. 48:735-740.
21. Jacob, C. O., R. Arnon, and R. A. Finkelstein. 1986. Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides. Infect. Immun. 52:562-567.
22. Klipstein, F. A., R. F. Engert, and R. A. Houghten. 1986. Immunisation of volunteers with a synthetic peptide vaccine for enterotoxigenic Escherichia coli. Lancet i:471-473.
23. Marcello, A., A. Loregian, A. Cross, H. Marsden, T. R. Hirst, and G. Palù. 1994. Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc. Natl. Acad. Sci. USA 91:8994-8998.
24. Marcello, A., A. Loregian, G. Palú, and T. R. Hirst. 1994. Efficient extracellular production of hybrid E. coli heat-labile enterotoxin B subunits in a marine vibrio. FEMS Microbiol. Lett. 117:47-52.
25. McKenzie, S. J., and J. F. Halsey. 1984. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 133:1818-1824.
26. Medaglini, D., G. Pozzi, T. P. King, and V. A. Fischetti. 1995. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc. Natl. Acad. Sci. USA 92:6868-6872.
27. Medaglini, D., C. M. Rush, P. Sestini, and G. Pozzi. 1997. Commensal bacteria as vehicles for mucosal vaccines against sexually transmitted diseases: vaginal colonisation with recombinant streptococci includes local and systemic antibodies in mice. Vaccine 15:1330-1337.
28. Mosmann, T. R., and R. L. Coffman. 1989. ThI and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immun. 7:145-173.
29. Nakagawa, I., I. Takahashi, H. Kiyono, J. R. McGhee, and S. Hamada. 1996. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches. J. Infect. Dis. 173:1428-1436.
30. Nashar, T. O., T. Amin, A. Marcello, and T. R. Hirst. 1993. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 11:235-240.
31. Nashar, T. O., H. M. Webb, S. Eaglestone, N. A. Williams, and T. R. Hirst. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. USA 93:226-230.
32. Newton, S. M. C., C. O. Jacob, and B. A. D. Stocker. 1989. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244:70-72.
33. Oggioni, M. R., R. Manganelli, M. Contorni, M. Tommasino, and G. Pozzi. 1995. Immunization of mice by oral colonization with live recombinant commensal streptococci. Vaccine 13:775-779.
34. Oggioni, M. R., D. Medaglini, L. Romano, F. Peruzzi, T. Maggi, L. Lozzi, L. Bracci, M. Zazzi, F. Manca, P. E. Valensin, and G. Pozzi. 1999. Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii. AIDS Res, Hum. Retroviruses 15:451-459.
35. Oggioni, M. R., and G. Pozzi. 1996. A host-vector system for heterologous gene expression in Streptococcus gordonii. Gene 169:85-90.
36. Pizza, M. G., M. R. Fontana, M. M. Giuliani, M. Domeneghini, C. Magagnoli, V. Giannelli, D. Nucci, W. Hol, R. Manetti, and R. Rappuoli. 1994. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 180: 2147-2153.
37. Pozzi, G., M. Contorni, M. R. Oggioni, R. Manganelli, M. Tommasino, F. Cavalieri, and V. A. Fischetti. 1992. Delivery and expression of a heterologous antigen on the surface of streptococci. Infect. Immun. 60:1902-1907.
38. Pozzi, G., R. A. Musmanno, P. M. J. Lievens, M. R. Oggioni, P. Plevani, and R. Manganelli. 1990. Method and parameters for genetic transformation of Streptococcus sanguis Challis. Res. Microbiol. 141:659-670.
39. Pozzi, G., M. R. Oggioni, R. Manganelli, and V. A. Fischetti. 1992. Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Res. Microbiol. 143:449-459.
40. Pozzi, G., M. R. Oggioni, R. Manganelli, D. Medaglini, V. A. Fischetti, D. Fenoglio, M. T. Valle, A. Kunkl, and F. Manca. 1994. Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. Vaccine 12:1071-1077.
41. Pozzi, G., M. R. Oggioni, and D. Medaglini. 1997. Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. In G. Pozzi and J. M. Wells (ed.), Gram-positive bacteria. Vaccine vehicles for mucosal immunization. RG Landes, Austin, Tex.
42. Rescigno, M., S. Citterio, C. Thery, M. Rittig, D. Medaglini, G. Pozzi, S. Amigorena, and P. Ricciardi-Castagnoli. 1998. Bacteria-induced neo-biosynthesis, stabilization and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95:5229-5234.
43. Sanchez, J., S. Johansson, B. Lowenadler, A. M. Svennerholm, and J. Holmgren. 1990. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination. Res. Microbiol. 141:971-979.
44. Sanchez, J. L., B. Vasquez, R. E. Begue, R. Meza, G. Castellares, C. Cabezas, D. M. Watts, A. M. Svennerholm, J. C. Sadoff, and D. N. Taylor. 1994. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet 344:1273-1276.
45. Schodel, F., and H. Will. 1989. Construction of a plasmid for expression of foreign epitopes as fusion proteins with subunit B of Escherichia coli heat-labile toxin. Infect. Immun. 57:1347-1350.
46. Sixma, T. K., S. E. Pronk, K. H. Kalk, E. S. Wartna, B. A. M. van Zanten, B. Witholt, and W. G. J. Hol. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351:371-377.
47. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647.
48. Svennerholm, A. M., D. A. Sack, J. Holmgren, and P. K. Bardhan. 1982. Intestinal antibody responses after immunisation with cholera B subunit. Lancet i:305-308.
49. Tacket, C. O., H. S. Mason, G. Losonsky, J. D. Clements, M. M. Levine, and C. J. Arntzen. 1998. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:607-609.
50. Takahashi, I., H. Kiyono, R. J. Jackson, K. Fujihashi, H. F. Staats, S. Hamada, J. D. Clements, K. L. Bost, and J. R. McGhee. 1996. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect. Immun. 64:1290-1298.
51. Takahashi, I., M. Marinaro, H. Kiyono, R. J. Jackson, I. Nakagawa, K. Fujihashi, S. Hamada, J. D. Clements, K. L. Bost, and J. R. McGhee. 1996. Mechanisms for mucosal immunogenicity and adjuvanticity of Escherichia coli labile enterotoxin. J. Infect. Dis. 173:627-635.
52. Toida, N., G. Hajishengallis, H. Y. Wu, and M. W. Russel. 1997. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues. Infect. Immun. 65:909-915.
53. Venwij, W. R., L. de Haan, M. Holtrop, E. Agsteribbe, R. Brands, G. J. M. van Scharrenburg, and J. Wilschut. 1998. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretery IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 16:2069-2076.
54. Waldor, M. K., and J. J. Mekalanos. 1996. Progress toward live-attenuated cholera vaccines, p. 229-240. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.
55. Winner, L., III, J. Mack, R. Weltzin, J. J. Mekalanos, J. P. Kraehenbuhl, and M. R. Neutra. 1991. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 59:977-982.
56. Wu, H. Y., and M. W. Russel. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:314-322.
57. Xu-Amano, J., R. J. Jackson, K. Fujihashi, H. Kiyono, H. F. Staats, and J. R. McGhee. 1994. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903-911.